glp 1 south korea tightens oversight as GLP-1 obesity drug misuse rises GLP-1 Meds Linked to 265

Least stable: Large peptides and complex proteins with extensive post-translational modifications

The stained sections were cleared by two dips in 0.5% acetic acid water

Oral formulations will grow to capture 25% share as bioavailability improves and new small-molecule GLP-1s reach the market, appealing to segments seeking greater convenience or avoiding injection-site issues

time 24 (n) 22 (n) Pellegrini 52% 0.48 [0.33-0.70] death 138 (n) 726 (n) Pourhoseingholi 11% 0.89 [0.68-1.18] death 65/309 274/2,159 Taher (DB RCT) 18% 0.82 [0.43-1.58] death 12/47 14/45 Assimakopoulos 97% 0.03 [0.00-0.30] death 2/42 12/40 Avdeev 69% 0.31 [0.03-2.72] death 1/24 3/22 STORM Faverio (PSW) -19% 1.19 [0.85-1.66] death 91/572 44/329 Ramadhan -135% 2.35 [0.33-16.9] death 11/75 1/16 Izquierdo 26% 0.74 [0.63-0.88] death 136/2,071 1,935/17,137 Deli (RCT) 14% 0.86 [0.64-1.17] death 24/39 37/52 Intubated patients Faria-Gonzlez 39% 0.61 [0.34-1.09] death 10/38 44/102 Intubated patients Mousapour (DB RCT) 2% 0.98 [0.26-3.64] death 4/42 4/41 Rahimi (SB RCT) 33% 0.67 [0.40-1.11] death 10/20 15/20 ICU patients avu (ICU) -13% 1.13 [0.85-1.50] death 52/97 44/93 ICU patients Panahi (RCT) 92% 0.08 [0.03-0.22] death 4/125 49/125 Inhaled Gamarra-Mo

Adults (2019-2024) Prescription Patterns and Healthcare Provider Trends Advanced practice practitioners and primary care physicians increasingly prescribe these medications, with APPs' share rising from 25.3% to 40.6% between 2017 and 2024 ^22